Read Pharmaceutical news articles from recent Pharmaceutical headlines
 
Google
Home » Pharmaceutical Articles » George Georges Honored for Accomplishments in Medicine


George Georges Honored for Accomplishments in Medicine

George Georges has executed integrated medical affairs plans for seven pharmaceutical products

    WHITEHOUSE STATION, NJ, June 15, 2010 /Pharmaceutical PR News/ -- George Georges, Associate Vice President of Allergy, Respiratory, and Anti-Infectives for Sanofi-Aventis U.S. LLC., has been recognized by Cambridge Who's Who for demonstrating dedication, leadership and excellence in medical research.

An associate vice president within the US Medical Affairs division at Sanofi-Aventis U.S. LLC, Dr. Georges' expertise is in pulmonary and critical care. He develops and executes integrated medical affair plans, and manages the medical aspect of significant and profitable pharmaceutical products. He has established and executed integrated medical affairs plans for seven products and contributed to medically significant and profitable global launches. Sanofi-Aventis U.S. LLC. markets brand-name pharmaceuticals, including Allegra , Nasacort AQ, Lantus , Taxotere , Lovenox , Plavix , and Ambien .

Dr. Georges received his MD from the American University of Beirut in 1990. He subsequently completed a residency in internal medicine at University Hospitals of Cleveland, and a fellowship in pulmonary diseases & critical care medicine at University of Colorado Health Sciences Ctr. He has always been passionate about life sciences and wanted to contribute to improving people's health on both the individual and population levels. A member of the American Thoracic Society and the American College of Chest Physicians, he attributes his success to hard work, world-class academic and professional mentors, indispensable family support and his unwavering commitment to excellence and integrity.

For more information about Sanofi-Aventis U.S. LLC., visit http://www.sanofi-aventis.us.

About Cambridge Who's Who
With over 400,000 members representing every major industry, Cambridge Who's Who is a powerful networking resource that enables professionals to outshine their competition, in part through effective branding and marketing. Cambridge Who's Who employs similar public relations techniques to those utilized by Fortune 500 companies and makes them cost-effective for members who seek to take advantage of its career enhancement and business advancement services. Cambridge is pleased to welcome its new Executive Director of Global Branding and Networking, Donald Trump Jr., who is eager to share his extensive experience in this arena with members.

Cambridge Who's Who membership provides individuals with a valuable third party endorsement of their accomplishments and gives them the tools needed to brand themselves and their businesses effectively. In addition to publishing biographies in print and electronic form, it offers an online networking platform where members can establish new professional relationships.

Headquartered in Long Island's premier office building, RXR Plaza, the Cambridge Who's Who staff spans more than 10 departments and comprises a team of nearly 200 highly skilled and dedicated employees. Together they work to provide members with the recognition and exposure needed to further their careers, expand their businesses and network effectively in an economy where referrals are more important than ever.

For more information, please visit http://www.cambridgeregistry.com.


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com
Press Release Contact Information:

Ellen Campbell
Cambridge Who's Who
Public Relations
498 RXR Plaza, West Tower
Uniondale, NY
USA 11556
Voice: 516-535-1515 x1266
Website: Visit Our Website
 
 
PHARMACEUTICAL ARCHIVE SEARCH
 
SUBMIT PHARMACEUTICAL NEWS
Submit your Pharmaceutical story